What is Soliris: Uses, Warnings & Interactions

Updated May 14, 2025  •  Published Sep 24, 2021

Soliris overview

BRAND NAMES:

  • Soliris

Generic Names:

  • Soliris

Uses:

  • Treats paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD).

Therapeutic Classes:

  • Blood Modifier Agent

Forms:

  • Injectable

How it’s taken:

  • By injection

What is Soliris used for?

Soliris is selective immunosuppressant used for the treatment of anemia caused by paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. It is also used to treat myasthenia gravis and other conditions as prescribed by your doctor. Soliris inhibits certain proteins in the blood that usually cause the destruction of red blood cells in patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is available to children and adults as an intravenous injection.

What form(s) does Soliris come in

  • Injectable

What are common Soliris doses?

  • Vial 30ML of 300MG/30ML

Common Soliris prescriptions

  • Soliris
    30ml of 300mg/30ml vial

How to take Soliris

  • Injection routeYour doctor will prescribe your dose and schedule. This medicine is given through a needle placed in a vein. The medicine must be injected slowly, so your IV will need to stay in place for at least 35 minutes in adults and 1 to 4 hours in children.

  • Injection routeA nurse or other health provider will give you this medicine.

  • This medicine should come with a Medication Guide. Ask your pharmacist for a copy if you do not have one.

  • Missed dose: Injection routeCall your doctor or pharmacist for instructions.

What to do if you miss a dose of Soliris

Soliris contraindications

  • This medicine is not right for everyone. You should not receive it if you had an allergic reaction to eculizumab or if you have a meningococcal infection. You should not receive this medicine if you have not been vaccinated against meningitis infection unless your doctor decides that urgent treatment with eculizumab is needed.

Soliris warnings

  • Tell your doctor if you are pregnant or breastfeeding, or if you have blood or bone marrow problems (including neutropenia), a weak immune system, or any kind of infection.

  • This medicine can increase your risk of serious infections, including meningococcal infection. You will need to be vaccinated against meningococcal infection at least 2 weeks before you start treatment with this medicine. You may also be given antibiotic medicines for 2 weeks to prevent infections if you are to use this medicine right away. You will also be given a patient safety card that lists the symptoms of infection and what to do if you have them. Carry the card with you at all times. Show the card to any doctor who treats you.

  • This medicine can also cause an infusion reaction that can be life-threatening.

  • For patients with PNH: When you stop receiving this medicine, you could develop hemolysis (breakdown of red blood cells). Your doctor will monitor you for at least 8 weeks.

  • For patients with aHUS: When you stop receiving this medicine, you could develop a type of blood clot called thrombotic microangiopathy. Your doctor will monitor you for at least 12 weeks to watch for this.

  • Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.

Soliris interactions

  • Tell your doctor if you are pregnant or breastfeeding, or if you have any kind of infection.

  • This medicine can increase your risk of serious infections, including meningococcal infection. You will need to be vaccinated against meningococcal infection at least 2 weeks before you start treatment with this medicine. You will also be given a patient safety card that lists the symptoms of infection and what to do if you have them. Carry the card with you at all times. Show the card to any doctor who treats you.

  • This medicine can also cause an infusion reaction that can be life-threatening.

  • For patients with PNH: When you stop receiving this medicine, you could develop hemolysis (breakdown of red blood cells). Your doctor will monitor you for at least 8 weeks.

  • For patients with aHUS: When you stop receiving this medicine, you could develop a type of blood clot called thrombotic microangiopathy. Your doctor will monitor you for at least 12 weeks to watch for this.

  • Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.

Soliris side effects

Serious Side Effects

  • Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing

  • Change in how much or how often you urinate

  • Confusion, sensitivity to light, severe headache, nausea, vomiting, stiff neck

  • Fast or uneven heartbeat

  • Fever, chills, cough, sore throat, body aches

  • Rapid weight gain, swelling in your hands, ankles, or feet

  • Unusual bleeding, bruising, weakness

Less Serious Side Effects

  • Back pain

  • Diarrhea, stomach pain

  • Pain, itching, burning, swelling, or a lump under your skin where the needle is placed

  • Runny or stuffy nose

Subscribe to our savings newsletter

Health education, drug info, wellness & more

By clicking 'Subscribe', I agree to SingleCare's Terms & Conditions.